Therapeutic Area
Latest
- Journals
- Articles
- Abstracts
- News
- Podcasts
- Videos & Webinars
About Us
Contributors
Newsletters & Alerts

You must accept all conditions before being able to view the post

Therapeutic Area
Allergy & Immunology

Cardiology

Dermatology

Diabetes

Flagship Journal

Gastroenterology

General Healthcare

Hematology

Hepatology

Innovations

Interventional Cardiology

Microbiology & Infectious Diseases

Nephrology

Neurology

Oncology

Radiology

Reproductive Health

Respiratory

Rheumatology

Urology
Latest
Journals

Articles

Abstracts

News

Podcasts

Videos & Webinars
About Us
Careers

Partners & Directory

Compliance

Open Access & Copyright

Contact Us
Contributors
Authors

Peer Reviewers

Submit a Paper

Editorial Board
Newsletters & Alerts

Home Oncology Pembrolizumab Shows Promising Activity Against Head and Neck Cancer

Pembrolizumab Shows Promising Activity Against Head and Neck Cancer

2nd June 2015

Share:

Related To This Subject

6th

December

Navigating the Integration of Immuno-Oncology Into the Perioperative Muscle-Invasive Urothelial Carcinoma Treatment Landscape

17 Mins

5th

December

Targeting Fibroblast Growth Factor Receptor Alterations in Cholangiocarcinoma and Other Solid Tumours: A New Frontier in Personalised Medicine

More articles

Flagship Journal

15 Mins

2nd December 2022

EGFR-Mutant Non-small Cell Lung Cancer: State-of-the-Art and Future Perspectives

30th September 2022

Infographic: ESMO Recommendations for Diagnosis and Staging of Metastatic Non-Small-Cell Lung Cancer

22 Mins

20th September 2022

Novel Biomarkers and Drug Targets in Non-Small Cell Lung Cancer

Featured journals

December 2022

EMJ Oncology 10 [Supplement 12] 2022

November 2022

EMJ Oncology 10 [Supplement 11] 2022

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.

Therapeutic Area

Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Nephrology
Neurology
Oncology
Reproductive Health
Respiratory
Rheumatology
Urology

About Us

About Us
GOLD
Careers
Partners & Directory
Compliance
Open Access & Copyright
Contact Us
Events
Contributors
Newsletters & Alerts
Media Pack
FAQ

Copyright © 2022 European Medical Group LTD trading as European Medical Journal. All rights reserved. European Medical Journal is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.

Ts & Cs Privacy Policy Cookie Policy

Website by Vibe Agency

Proud to be ISO9001 Certified.

The ISO 9001 standard is an internationally recognised standard that is based on a number of quality management principles including a strong customer focus, the management of process change, effective methods of reducing non- compliance, and the continual improvement in the quality of our services.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.